Literature DB >> 17678939

Preventing chronic obstructive pulmonary disease: what is known and what needs to be done to make a difference to the patient?

Robert A Wise1, Donald P Tashkin.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable systemic disease with symptoms that overlap other respiratory illnesses. An estimated 24 million adults in the United States have COPD, but >50% of them are misdiagnosed or undiagnosed. Spirometry remains the "gold standard" for diagnosing COPD and for monitoring the progression of the disease. Cigarette smoking is the main cause of COPD; therefore, smoking cessation is an integral component of any program to reduce COPD risk and delay or limit the progression of airflow obstruction. Influenza vaccinations will also reduce acute respiratory illness in patients with COPD. With increasing awareness of COPD and earlier diagnosis, implementation of treatment guidelines and smoking-cessation efforts may lead to more effective management of this disease, which is projected to be the third leading cause of death in the United States by 2020.

Entities:  

Mesh:

Year:  2007        PMID: 17678939     DOI: 10.1016/j.amjmed.2007.04.008

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Chronic obstructive pulmonary disease: a view from the NHLBI.

Authors:  Antonello Punturieri; Thomas L Croxton; Gail G Weinmann; James P Kiley
Journal:  Am J Respir Crit Care Med       Date:  2008-09-01       Impact factor: 21.405

2.  Diagnosing and treating COPD: understanding the challenges and finding solutions.

Authors:  Len Fromer
Journal:  Int J Gen Med       Date:  2011-10-28

3.  SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs.

Authors:  Annie Standaert-Vitse; Cécile-Marie Aliouat-Denis; Anna Martinez; Sara Khalife; Muriel Pottier; Nausicaa Gantois; Eduardo Dei-Cas; El Moukhtar Aliouat
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

4.  Long-term efficacy of a rural community-based integrated intervention for prevention and management of chronic obstructive pulmonary disease: a cluster randomized controlled trial in China's rural areas.

Authors:  X Yuan; Y Tao; J P Zhao; X S Liu; W N Xiong; J G Xie; W Ni; Y J Xu; H G Liu
Journal:  Braz J Med Biol Res       Date:  2015-08-28       Impact factor: 2.590

5.  The study design and rationale of the randomized controlled trial: translating COPD guidelines into primary care practice.

Authors:  Donna R Parker; Charles B Eaton; David K Ahern; Mary B Roberts; Caitlin Rafferty; Roberta E Goldman; F Dennis McCool; Joseph Wroblewski
Journal:  BMC Fam Pract       Date:  2013-05-06       Impact factor: 2.497

6.  Mortality and life expectancy of Yokkaichi asthma patients, Japan: late effects of air pollution in 1960-70s.

Authors:  Peng Guo; Kazuhito Yokoyama; Masami Suenaga; Hirotaka Kida
Journal:  Environ Health       Date:  2008-02-26       Impact factor: 5.984

7.  Adoption and adherence to chronic obstructive pulmonary disease GOLD guidelines in a primary care setting.

Authors:  Salim Surani; Akshar Aiyer; Stephen Eikermann; Timothy Murphy; Pranav Anand; Joseph Varon; David Vanderheiden; Alamgir Khan; Antonio Guzman
Journal:  SAGE Open Med       Date:  2019-04-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.